Search Orphan Drug Designations and Approvals
-
Generic Name: | Tolcapone |
---|---|
Date Designated: | 12/24/2013 |
Orphan Designation: | Treatment of transthyretin amyloidosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Corino Therapeutics, Inc. 57 West 57th Street 18th Floor New York, New York 10019 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-